Oligo-strategies in female cancer: Breast and gynaecological at the frontier of SABR
Fran Duane,
Ireland;
Sorina Alexandra Niculescu ,
Romania
This session will focus on the role of metastases-directed therapy in the form of stereotactic ablative body radiotherapy in the treatment of oligometastatic breast and gynaecological malignancies. Ongoing and future studies will be summarised. Selection criteria will be presented emphasising the importance of considering varying biological subtypes. Decision-making around how to integrate local therapy with systemic therapies will be addressed. Importantly this symposium will include the patient's perspective to better understand what is most important to patients in terms of treatment goals and unmet needs.
Symposium
Clinical